Ruxolitinib Posted on December 24, 2012December 24, 2012 by 3dciencia Ruxolitinib is a potent and selective Janus kinase (JAK) 1 and 2 inhibitor, Aproved for therapy, in patients with myelofibrosis. Share this:TwitterFacebookLike this:Like Loading... Related